Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 10/2014

01-10-2014 | Correspondence

Bevacizumab in advanced cervical cancer

Authors: P. J. Vlachostergios, C. N. Papandreou

Published in: Clinical and Translational Oncology | Issue 10/2014

Login to get access

Excerpt

Angiogenesis and hypoxia have been proven to be the established players in cervical cancer progression, and relevant markers, including vascular endothelial growth factor, carbonic anhydrase 9 and hypoxia-inducible factor-1α was proven to be associated with poor prognosis in cervical cancer patients primarily treated with chemoradiation [1]. …
Literature
1.
Gadducci A, Guerrieri ME, Greco C. Tissue biomarkers as prognostic variables of cervical cancer. Crit Rev Oncol Hematol. 2013;86:104–29.PubMedCrossRef
2.
Tewari KS, Sill MW, Long HJ 3rd, Penson RT, Huang H, Ramondetta LM, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370:734–43.PubMedCrossRefPubMedCentral
3.
Wolfson AH, Varia MA, Moore D, Rao GG, Gaffney DK, Erickson-Wittmann BA, et al. ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancer. Gynecol Oncol. 2012;125:256–62.PubMedCrossRef
4.
Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, et al. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma. Int J Radiat Oncol Biol Phys. 2014;88:101–5.PubMedCrossRef
5.
Zighelboim I, Wright JD, Gao F, Case AS, Massad LS, Mutch DG, et al. Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer. Gynecol Oncol. 2013;130:64–8.PubMedCrossRef
Metadata
Title
Bevacizumab in advanced cervical cancer
Authors
P. J. Vlachostergios
C. N. Papandreou
Publication date
01-10-2014
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 10/2014
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-014-1205-7

Other articles of this Issue 10/2014

Clinical and Translational Oncology 10/2014 Go to the issue

Research Article

Looking for complementary alternatives to CTCAE for skin toxicity in radiotherapy: quantitative determinations

Educational Series – Blue Series

New biological markers in the decision of treatment of head and neck cancer patients

Research Article

Second primary malignancies in patients with neuroendocrine tumors

Educational Series – Red Series

Subcutaneous trastuzumab: drug development and current position

Research Article

Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists

Special Article

TTD consensus document on the diagnosis and management of exocrine pancreatic cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits